| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.0051 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |